This session will highlight the critical role synthetic biology plays in developing vaccines, a need highlighted by the global health crisis. This conversation will also expand on vaccine development within the cancer community and speak to advancements within personalized medicine. Our expert panel will discuss the latest advancements in synthetic biology that enable faster, more effective vaccine production, crucial for responding to emerging and specialty diseases. This session will also cover various cancer vaccines and the possible use of the N of 1 study. Attendees will gain insights into people designing human vaccines using various bioinformatics tools and learn best practices to get vaccines more rapidly approved through the FDA.

This session will highlight how single-cell sequencing technologies are transforming our ability to identify novel therapeutic targets, optimize engineered cell lines, and accelerate the drug discovery pipeline. By dissecting cellular heterogeneity at unprecedented resolution, these approaches are revealing intricate gene-expression patterns and pathway dynamics that guide the design of synthetic biological systems with greater precision. From refining the selection of promising drug candidates to informing the rational engineering of cell-based models, the discussion will explore how single-cell insights are redefining the frontiers of synthetic biology and unlocking new opportunities for innovative drug discovery.